Positive Outcomes From an Infectious Disease Crisis
No crisis should go unexploited for its potential to improve health care delivery.
No crisis should go unexploited for its potential to improve health care delivery.
Investigators assessed factors associated with 90- and 365-day mortality among veterans infected carbapenem-resistant Acinetobacter baumanii and carbapenem-resistant Pseudonomas aeruginosa.
Researchers assessed whether adeno-associated virus vectored immunoprophylaxis with AAV8-VRC07 produces broadly neutralizing antibodies in patients with HIV.
Tissue inhibitor of metalloproteinases 2 (TIMP-2) and insulinlike growth factor binding protein 7 (IGFBP7) could be used for AKI staging.
Researchers assessed diagnostic testing patterns among patients with suspected tick-borne diseases in North Carolina.
Researchers assessed whether CD4+ T-cell count predicts treatment outcomes in patients with cancer who received direct-acting antivirals for hepatitis C.
Researchers assessed the potential for COVID-19 transmission via contaminated surfaces.
Researchers assessed the effects of sofosbuvir/ledipasvir vs nitazoxanide when added to standard care for the treatment of mild to moderate COVID-19.
Specialized imaging shows that posthospitalized COVID-19 patients and nonhospitalized patients with post-COVID-19 condition have lung abnormalities.
Researchers evaluated liver test abnormalities in patients hospitalized with COVID-19 and assessed cytokine levels in individuals with vs without abnormal test results.